Show simple item record

dc.contributor.authorYuana, Hindri Mufti
dc.date.accessioned2024-12-19T06:59:22Z
dc.date.available2024-12-19T06:59:22Z
dc.date.issued2021
dc.identifier.urihttps://dspace.uc.ac.id/handle/123456789/7770
dc.descriptionDiabetes Mellitus (DM) is a chronic metabolic syndrome characterized by hyperglycemia due to impaired insulin secretion or insulin action. The incidence of chronically DM that triggers a decrease of renal function until become End State Renal Disease condition. Data in the United States by the CDC in 2008 showed 44% of new cases of kidney failure due to DM. PROLANIS is a program issued by the Indonesian Ministry of Health to prevent the worsening of the condition of PROLANIS participants. Due to COVID-19 pandemic in Indonesia, PROLANIS activities didn’t run as usual. The purpose of this study was to analyze the renal function of DM patients with PROLANIS through the value of the UACR at the Made Health Center and Simomulyo Health Center in 2021 through monitoring for 3 months. This study is an experimental study with a cohort design (pre-post) with a prospective flow which was processed using the Wilcoxon signed rank test statistical test. The total sample is 28 people. The results showed that the UACR at the Made Health Center (p=0,2 78 ), the UACR at the Simomulyo Health Center (p=0,0 99 ). It can be concluded that there is no significant difference in the value of UACR at the Made Health Center and Simomulyo Health Center after monitoring for 3 months.en_US
dc.description.abstractDiabetes Melitus (DM) merupakan sindroma metabolisme kronis yang ditandai dengan kondisi hiperglikemia akibat gangguan sekresi insulin atau kerja insulin. Kejadian DM yang berlangsung secara kronis memicu terjadinya penurunan fungsi ginjal hingga berakhir pada kondisi End State Renal Disease . Data di United State oleh CDC pada tahun 2008 menunjkan 44% kasus baru gagal ginjal akibat DM. Program Pengelolaan Penyakit Kronis (PROLANIS) merupakan suatu program yang dikeluarkan oleh Kementerian Kesehatan Indonesia untuk mencegah perburukan kondisi peserta PROLANIS. Karena adanya pandemi COVID -19 di Indonesia menyebabkan tidak berjalannya kegiatan PROLANIS seperti biasanya. Tujuan penelitian ini a dalah menganalisis fungsi ginjal pasien DM peserta PROLANIS melalui nilai R asio A lbumin K reatinin Urin (RAK Urin) di Puskesmas Made dan Puskesmas Simomulyo tahun 2021 melalui pemantauan selama 3 bulan. Penelitian ini merupa kan penelitian eksperimental dengan desain cohort (pre - post) dengan alur prospective yang diolah menggunakan uji statistik Wilcoxon signed rank test. Total sampel a dalah 28 orang. Hasil penelitian menunjukan RAK Urin Puskesmas Made ( p=0,2 78 ), RAK Urin Pusk esmas Simomulyo ( p=0, 099 ). Maka dapat disimpulkan tidak terdapat perbedaan signifikan nilai RAK Urin di Puskesmas Made dan Puskesmas Simomulyo setelah pemantauan selama 3 bulan.en_US
dc.publisherUniversitas Ciputraen_US
dc.subjectDiabetes Melitusen_US
dc.subjectFungsI Ginjalen_US
dc.subjectRAK Urinen_US
dc.subjectPROLANISen_US
dc.titlePENGARUH PANDEMI COVID-19 TERHADAP PROGRAM PENGELOLAAN PENYAKIT KRONIS PADA PENDERITA DM TIPE 2 DENGAN RASIO ALBUMIN KREATININ URIN DI PUSKESMAS MADE DAN PUSKESMAS SIMOMULYO SURABAYAen_US
dc.typeThesisen_US
dc.identifier.kodeprodi11201
dc.identifier.nim0606011810006


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record